指南与共识产科母胎医学

单胎妊娠血管前置:基于国际专家共识的诊断与临床管理

Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus.
指南 / 共识 · Am J Obstet Gynecol · 2024-03-15

本研究通过4轮焦点小组讨论和3轮Delphi调查,由57名来自13个国家的国际专家参与,就血管前置的诊断与管理达成26条共识,包括所有妊娠应在中孕期解剖扫描时筛查、低置胎盘或前置胎盘孕妇约32周行经阴道多普勒超声排除、无症状无早产风险者可门诊管理、无症状患者于35至37周择期剖宫产,但常规住院、避免性交及三维超声诊断未达成共识。

要点

  • 所有妊娠应在中孕期解剖扫描时常规检查脐带插入处并对宫颈区域行彩色多普勒扫查以筛查血管前置。
  • 中孕期发现低置胎盘或前置胎盘者,约32周行经阴道多普勒超声以排除血管前置。
  • 无症状且无早产风险因素的血管前置患者可门诊管理,并于35至37周择期剖宫产。

核心结论

  • 国际专家小组通过焦点小组讨论和Delphi流程,就血管前置的定义、筛查、临床管理和分娩时机达成共识,可为制定新临床指南提供参考。

研究设计与样本

  • 研究采用4轮焦点小组讨论和3轮Delphi调查,对象为根据血管前置发表记录选出的国际专家小组。
  • 先由20名专家组成焦点小组讨论小组,确定血管前置诊断和管理中未解决的问题。
  • 随后向全体专家小组发送3轮匿名电子调查,问题以5点Likert量表评分(从「非常不同意」=1至「非常同意」=5),共识定义为中位评分为5。
  • 共邀请68名国际专家参与,57名参与,来自5大洲13个国家,其贡献超过已发表血管前置队列研究及国家和国际学会指南的80%。
  • 第1、2、3轮完成率分别为84%、93%、91%,71%完成全部3轮。

主要发现

  • 专家小组就血管前置诊断和管理关键点达成26条共识声明。
  • 关于胎儿血管与宫颈内口间距离的定义未达成一致,但定义不应限于2厘米距离。
  • 所有妊娠应在中孕期解剖扫描时常规检查胎盘脐带插入处并对宫颈区域行彩色多普勒扫查以筛查血管前置。
  • 中孕期发现低置胎盘或前置胎盘时,应在约32周行经阴道超声加多普勒以排除血管前置。
  • 无症状且无早产风险因素的患者可门诊管理;无症状血管前置患者应在35至37周择期剖宫产。

关键数值与推荐

  • 共识定义为中位评分为5;中位评分≤3的声明视为未达成共识并排除;中位评分为4的声明修订后在下一轮重新呈现。
  • 所有妊娠应在中孕期解剖扫描时常规检查胎盘脐带插入处并对宫颈区域行彩色多普勒扫查以筛查血管前置(共识声明)。
  • 中孕期发现低置胎盘或前置胎盘时,约32周行经阴道超声加多普勒以排除血管前置(共识声明)。
  • 无症状且无早产风险因素的血管前置患者可门诊管理(共识声明)。
  • 无症状血管前置患者应在35至37周择期剖宫产(共识声明)。

临床怎么用

  • 所有妊娠在中孕期解剖扫描时常规检查胎盘脐带插入处并对宫颈区域行彩色多普勒扫查以筛查血管前置。
  • 中孕期发现低置胎盘或前置胎盘时,约32周行经阴道超声加多普勒以排除血管前置。
  • 无症状且无早产风险因素的血管前置患者可门诊管理。
  • 无症状血管前置患者应在35至37周择期剖宫产。
  • 常规住院、避免性交及三维超声诊断血管前置未达成共识。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited data to guide the diagnosis and management of vasa previa. Currently, what is known is largely based on case reports or series and cohort studies. OBJECTIVE: This study aimed to systematically collect and classify expert opinions and achieve consensus on the diagnosis and clinical management of vasa previa using focus group discussions and a Delphi technique. STUDY DESIGN: A 4-round focus group discussion and a 3-round Delphi survey of an international panel of experts on vasa previa were conducted. Experts were selected on the basis of their publication record on vasa previa. First, we convened a focus group discussion panel of 20 experts and agreed on which issues were unresolved in the diagnosis and management of vasa previa. A 3-round anonymous electronic survey was then sent to the full expert panel. Survey questions were presented on the diagnosis and management of vasa previa, which the experts were asked to rate on a 5-point Likert scale (from "strongly disagree"=1 to "strongly agree"=5). Consensus was defined as a median score of 5. Following responses to each round, any statements that had median scores of ≤3 were deemed to have had no consensus and were excluded. Statements with a median score of 4 were revised and re-presented to the experts in the next round. Consensus and nonconsensus statements were then aggregated. RESULTS: A total of 68 international experts were invited to participate in the study, of which 57 participated. Experts were from 13 countries on 5 continents and have contributed to >80% of published cohort studies on vasa previa, as well as national and international society guidelines. Completion rates were 84%, 93%, and 91% for the first, second, and third rounds, respectively, and 71% completed all 3 rounds. The panel reached a consensus on 26 statements regarding the diagnosis and key points of management of vasa previa, including the following: (1) although there is no agreement on the distance between the fetal vessels and the cervical internal os to define vasa previa, the definition should not be limited to a 2-cm distance; (2) all pregnancies should be screened for vasa previa with routine examination for placental cord insertion and a color Doppler sweep of the region over the cervix at the second-trimester anatomy scan; (3) when a low-lying placenta or placenta previa is found in the second trimester, a transvaginal ultrasound with Doppler should be performed at approximately 32 weeks to rule out vasa previa; (4) outpatient management of asymptomatic patients without risk factors for preterm birth is reasonable; (5) asymptomatic patients with vasa previa should be delivered by scheduled cesarean delivery between 35 and 37 weeks of gestation; and (6) there was no agreement on routine hospitalization, avoidance of intercourse, or use of 3-dimensional ultrasound for diagnosis of vasa previa. CONCLUSION: Through focus group discussion and a Delphi process, an international expert panel reached consensus on the definition, screening, clinical management, and timing of delivery in vasa previa, which could inform the development of new clinical guidelines.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Oyelese Y, Javinani A, Gudanowski B, et al. Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus. Am J Obstet Gynecol. 2024. PMID: 38494071. doi:10.1016/j.ajog.2024.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。